Advertisement
Advertisement

ANNX

ANNX logo

Annexon Inc

4.98
USD
+0.1
+2.05%
Dec 18, 14:01 UTC -5
Open

Annexon Inc Profile

About

Annexon Inc. is a clinical-stage biopharmaceutical company. It engages in developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's product candidate includes ANX005 and ANX007, which are in clinical stage. Annexon Inc. is based in SAN FRANCISCO, Calif.

Info & Links

CEO

Douglas E. Love, Esq.

Headquarters

1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200
BRISBANE, CA 94005, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.annexonbio.com

Auditor

KPMG LLP

Share holders

28

Employees

71

Annexon Inc Statistics

Valuation Measures

Market Capitalization2

530.82M

Enterprise Value

451.28M

Enterprise Value/EBITDA(ttm)

-3.49

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-38.99%

Return on Invested Capital(ttm)

-39.43%

Return on Assets(ttm)

-33.90%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-129.45M

Net Income Available to Common(ttm)

-117.50M

Diluted EPS(ttm)

-1.05

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

110.13%

S&P 500 52-Week Change

27.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

106.59M

Dividend Yield

0.00%

Float4

93.09M

% Held by Insiders

12.67%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

340.12M

Total Cash Per Share(mrq)

3.19

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.18%

Quick Ratio(mrq)

17.18%

Book Value Per Share(mrq)

3.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.59

Free Cash Flow(ytd)

-82.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement